Evaluation of Modified ATRIA Risk Score in Predicting Mortality in Hospitalized Patients With COVID-19.

Creative Commons License

Aciksari G., Cetinkal G., Kocak M., Cag Y., Atici A., Altunal L. N. , ...More

The American journal of the medical sciences, vol.362, no.6, pp.553-561, 2021 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 362 Issue: 6
  • Publication Date: 2021
  • Doi Number: 10.1016/j.amjms.2021.06.001
  • Journal Name: The American journal of the medical sciences
  • Journal Indexes: Science Citation Index Expanded, Scopus, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.553-561
  • Keywords: SARS-CoV-2, COVID-19, ATRIA risk score, Risk stratification, Mortality, MORBIDITY


Background: As the Modified Anticoagulation and Risk Factors in Atrial Fibrillation Risk Score (M-ATRIA-RS) encompasses prognostic risk factors of novel coronavirus-2019 (COVID-19), it may be used to predict in-hospital mortality. We aimed to investigate whether M-ATRIA-RS was an independent predictor of mortality in patients hospitalized for COVID-19 and compare its discrimination capability with CHADS, CHA2DS2-VASc, and modified CHA2DS2-VASc (mCHA2DS2-VASc)-RS.